Version July 2025
| Advantages |
| Reduction in pelvic pain for the majority of patients and improved QOL |
| Avoids risk of damaging pelvic organs during surgery |
| Avoids risk of postoperative adhesion formation |
| Treats implants not visualized during surgery |
| Disadvantages |
| Side effects of medications |
| High recurrence rates after discontinuation |
| No effect on existing adhesions |
| No clinically significant long-term effect on endometriomas |
| Treatments involving suppression of ovulation also prevent pregnancy during the treatment period |
| No improvement in fertility potential |
